The description of atomic structure by Niels Bohr set the basis for the emergence of quantum physics. Based on these fundamentals, Einstein published in 1917 a paper on the amplification of energy by Stimulated Emission of Radiation as part of his quantum theories. In 1955, Townes and Gordon turned Einstein’s theories into practice, creating a coherent and amplified microwave device using ammonia gas in an optical medium. But it was at the beginning of the 1980s, that Anderson and Parrish published an article about the selective photothermolysis model which revolutionized clinical practice. The use of laser in photoaging began with CO2 (10,600 nm). In 1989, it was first used for resurfacing of a face with prominent photoaging. Ablative lasers have therefore had great popularity in the 1980s and 1990s, but prolonged postoperative time and significant risk of side effects have lowered the acceptance by patients. In 2004, the description of the fractionated radiation for the treatment of photoaging, by Mainstein, represented a great event. The stimulation of collagen occurred through fractional laser beams, which would reach the selected area while saving islands of sound skin. These islands accelerated the process of cicatrization of the treated tissue and shortened the postprocedure time. Furthermore, the fractionated radiation presented a smaller range of side effects, increasing the safety of the procedure. As mentioned earlier, as fractional lasers incise on the skin, they leave islands of healthy skin that accelerate recovery, while generating necrosis columns. Such necrosis columns remove damaged extracellular matrix material, allowing resettlement of fibroblasts. Such resettled fibroblasts, under the influence of a new tensile strength, restart to produce structures for extracellular matrix, such as collagen, elastin, and proteoglycans, in a more physiological way. Fractional lasers are considered by many dermatologists as the best choice in laser therapy for the treatment of photoaging.
BACKGROUNDFractional non-ablative lasers keep the epidermis intact, while fractional
ablative lasers remove it, making them theoretically more effective.OBJECTIVESTo evaluate the clinical and histological alterations induced by fractional
photothermolysis for treating photoaging, comparing the possible equivalence of
multiple sessions of 1540nm Erbium, to one session of 2940nm Erbium.METHODSEighteen patients (mean age 55.9) completed the treatment with three sessions of
1540nm fractional Erbium laser on one side of the face (50 mJ/mB, 15ms, 2 passes),
and one session of 2940nm on the other side (5mJ/mB, 0.25ms, 2 passes). Biopsies
were performed before and 3 months after treatment. Clinical, histological and
morphometric evaluations were carried out.RESULTSAll patients presented clinical improvement with no statistically significant
difference (p> 0.05) between the treated sides. Histopathology revealed a new
organization of collagen and elastic fibers, accompanied by edema, which was more
evident with the 2940nm laser. This finding was confirmed by morphometry, which
showed a decrease in collagen density for both treatments, with a statistical
significance for the 2940nm laser (p > 0.001).CONCLUSIONSThree 1540nm sessions were clinically equivalent to one 2940nm session. The edema
probably contributed to the positive results after three months, togheter with the
new collagen and elastic fibers organization. The greater edema after the 2940nm
session indicates that dermal remodeling takes longer than with 1540nm. It is
possible that this histological superiority relates to a more prolonged effect,
but a cohort longer than three months is needed to confirm that supposition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.